Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab versus macular laser for diabetic macular oedema
2010-021722-35Phase 4Completed
- Sponsor
- Moorfields Eye Hospital
- Start
- Aug 2010
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ranibizumab in diabetic macular edema (DME) (2 arms), sponsored by Moorfields Eye Hospital. Primary endpoint: Detailed retinal structure and function outcomes. Started Aug 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2010-021722-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021722-35.